Versameb
company
About
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
- Basel,Basel-Stadt,Switzerland
- 1 - 10
- https://versameb.com/
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- Fr6M
- Industries
- Biotechnology,Medical,Pharmaceutical
- Founded date
- Jan 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Legal Name
- Versameb AG
Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland managed by an experienced scientific and business pharmaceutical industry team.The company’s focus is the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNA molecules for customized protein expression and modification in multiple disease areas with high unmet medical need.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
Fr17.70M
Versameb has raised a total of
Fr17.70M
in funding over 2 rounds. Their latest funding was raised on
Jul 15, 2020 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 15, 2020 | Seed | Fr6M | — | — | — | Detail |
| Oct 17, 2019 | Seed | Fr6.40M | — | — | — | Detail |
| Dec 27, 2018 | Seed | Fr5.30M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Versameb is funded by 1 investors.
Penny Schiffer
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Penny Schiffer
|
— | Seed |
Employee Profiles
Number of Employee Profiles
7
Versameb has 7 current employee profiles, including
Board member Reinhard Ambros
Board member
Executive
Executive
Executive
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
